Construction and validation of an IRF4 risk score to predict prognosis and response to immunotherapy in hepatocellular carcinoma
- Resource Type
- Article
- Source
- In
International Immunopharmacology December 2022 113 Part A - Subject
- Language
- ISSN
- 1567-5769